GARD collaborating parties - WHO · Global Alliance against Chronic Respiratory Diseases GARD...

Global Alliance against Chronic Respiratory Diseases

www.who.int/gard

GARD collaborating parties

Elisabetta Minelli, Technical Officer

GARD General Meeting

1-2 June 2007

Seoul, Republic of Korea


www.who.int/gard

Overview

• The power of GARD collaborating parties

• Evolution of number of participants

• Current participants and observers

• Status of parties interested in GARD

• Should GARD keep growing?


www.who.int/gard

GARD is

• a voluntary alliance

• of national and international organizations, institutions and agencies

• working towards the common goal of improving global lung health

The power of GARD collaborating parties

StopTB Partnership, WHO


www.who.int/gard

WHO vision

Dr Brundtland, Address to WHA

"the global health field has seen

a steady increase in the

number of actors … as WHO,

we must reach out the many

stakeholders – in civil society,

in the private sector and in the

broad health and research

community"

Dr Chan, Address to WHA

One of the sixth-item agenda:

"managing partnerships to get

the best results in countries: (…)

performance within countries

improves when the multiple

activities of partners are

harmonized with national

priorities"


www.who.int/gard

Overview







www.who.int/gard

June 2004

WHO

ACAAI

ALAT

ARIA

ATS

EAACI

EFA

ERS

FILHA

FIRS

GA2LEN

GINA

GOLD

NHLBI

WAO

WHO-CC DU

Jan 2005

WHO

AAAAI

AAAF

ACAAI

ARIA

ATS

EAACI

EFA

ERS

FILHA

FIRS

GA2LEN

GINA

GOLD

ICC

INTERASMA

15

21

Oct 2002

WHO

EFA

Jan 2003

WHO

EFA

ARIA

2

3

Evolution of number of participants

KAF

NHLBI

WAO

WHO-CC DU

WHO-CC UCM

WONCA


www.who.int/gard

41

2006 General Meeting, BeijingWHO

AAA (D. Vervloet, France)

AAAAI (E. Simon, CAN)

AAAF (R. Pawankar, JAP)

ACAAI (M. Blaiss, USA)

AIMAR (C. Donner, ITA)

ALAT (C. Luna, ARG)

APAACI (T. Fukuda, JAP)

APSR (Y. Fukuchi, JAP)

ARIA (J. Bousquet, FRA)

ATS (P. Wagner, USA)

CNR-INMM (G. Rasi, ITA)

DLHA (DK)

EAACI (U. Wahn, GER)

ECARF (T. Zuberbier, GER)

EFA (S. Palkonen, FIN)

ERS (R. Dahl, DK)

FEMTEC (U. Solimene, ITA)

FILHA (M. Nieminen, FIN)

FIRS (A. Turnbull, SWI)

GA2LEN (P. Van Cauwenberge,

BEL)

GINA (P. O’Byrne, CAN)

GOLD (L. Fabbri, ITA)

ICC (L. Grouse, USA)

INTERASMA (I. Ansotegui,

SPA)

IPRAIS (J. Warner, UK)

IPCRG (A. Ostrem, UK)

KAF (Y. Kim, KOR)

KTL (P. Puska, FIN)

NHLBI (B. Alving, USA)

PSA (P., POL)

RSP (A. Chuchalin, RUS)

SFAIC (G.Pauli, FRA)

SIMER (W. Canonica,ITA)

SPAIC (M. Morais de Almeida)

SPLF (B. Housset, FRA)

The Union (N. Billo, FRA)

TTS (A. Kocabas, TUR)

WAO (C. Baena-Cagnani,

ARG)

WHO-CC DU (S. Makino, JAP)

WHO-CC GU (G. Joos, BEL)

WONCA (A. Loh, SIN)


www.who.int/gard

2007 General Meeting, Seoul

WHO

AAA (D. Vervloet)

AAAAI (T. Casale)

AAAF (R. Pawankar)

ACAAI (D. Ein)

AIMAR (C. Donner, ITA)

ALAT (P. Padilla)

ALLERG.O.S (C. Gallen)

APAACI (T. Fukuda)

APSR (Y. Fukuchi)

ARIA (J. Bousquet)

ATS (J. Heffner)

CCM (D. Greco)

CNR-INMM (G. Rasi)

DLHA (B. Hellquist)

EAACI (R. Gerth van Wijk)

ECARF (T. Zuberbier)

EFA (S. Palkonen)

ERS (G.Viegi)

FEMTEC (N. Storozhenko)

FILHA (R. Kauppinen)

FIRS (A. Turnbull)

GA2LEN (P. Van Cauwenberge)

GINA (E. Bateman)

GOLD (S. Buist)

GRA (I. Chkhaidze)

ICC (L. Grouse)

INTERASMA (I. Ansotegui)

IPRAIS (J. Warner)

IPCRG (N. Chavannes)

KAF (Y. Kim)

KTL (P. Puska)

NHLBI (J. Kiley)

PSA (M. Kowalski)

RSP (A. Chuchalin)

SFAIC (P. Scheinmann)

SIMER (G. D'Amato)

SPAIC (M. Morais de Almeida)

SPLF (P. Godard)

THE UNION (N. Billo)

TNSACI (O. Kalayci)

TTS (E. Sabri)

WAO (C. Baena-Cagnani, W.

Canonica)

WHO-CC DU (S. Makino)

WHO-CC GU (G. Joos)

WONCA (A.. Loh)

47


www.who.int/gard

Overview







www.who.int/gard

Current GARD participants

14

1422

5

2

5 3

Respiratory

Allergy

Primary care

Specific disease

Patient organizations

Govern. institutions

WHO coll. centres

Foundations

Total of 47 participants


www.who.int/gard

Current observers

Stallergens

Schering Plough Corporation

Sanofi-aventis

Pfizer Inc.

Novartis Pharma

Merck & Co.

GlaxoSmithKline

Chiesi Farmaceutici

Boehringer-Ingelheim

Astra Zeneca

Altana Pharma

11


www.who.int/gard

Overview







www.who.int/gard

Current status of parties interested in GARD

26

89

31

4 1

Second year DA signed

DA in the process to be

renewed

First DA

In the process of applying

No voluntary contribution

expected

Drop out

78 interested parties

31 in the process of applying Available in your folder


www.who.int/gard

New Applicants: Paying

• AIPO, Associazione Italiana

Pneumologi Ospedalieri

• ARF Allergy Research Foundation, UK

• ASC Asthma Society of Canada

• BTS Belgian Thoracic Society

• CTS Canadian Thoracic Society

• EFH Education for Health, UK

• EARS Euro-Asian Society, Republic of

Kazakhstan

• Egypt Society of Allergology and

Immunology

• Egyptian Society of Allergy, Asthma and

Immunology

• IFOS International Federation of Oto-

Rhino-Laryngolocial Societies

• KTS, Kyrgyz Thoracic Society

• JSA Japanese Society of Allergology

• NFAI Norwegian Society of Allergology and Clinical Immunopathology

• PHA Pulmonary Hypertension Association

• SAAAIC Société Algérienned'Asthmologie, d'Allergologie et d'Immunologie Clinique

• SAP Société Algérienne de Pneumophtisiologie

• SLAI Société Libanaise d’Allergie et d’Immunologie

• TSTM Tunisian Society of Thoracic Medicine

• UBSM Union of the Bulgarian Societies of Medicine

• Wyeth Foundation 20


www.who.int/gard

New Applicant: Non paying

• CIPA Czech Initiative for Asthma

• IRS International RhinologicSociety

• PTS Pan African Thoracic Society

• Tishreen University - Faculty of Medicine, Syria

• UM 1 University of Montpellier

• CRF Chest Research Foundation, India

• Egyptian Society of Chest Diseases and Tuberculosis

• MSTM Macedonian Society of Thoracic Medicine

• Pakistan Aga Khan University

• RRF Respiratory Research Foundation, India

• YAAC Yugoslav Association for Asthma and COPD

New Applicants: To be decided

5 6


www.who.int/gard

Overview







www.who.int/gard

Should GARD keep growing?

PROs

• An increasing variety of resources (technical -knowledge, capacities -and financial)

• A higher visibility and recognition in the area of chronic respiratory diseases

• A major strength at the political level


www.who.int/gard

Should GARD keep growing?

CONs

• Increasing difficulties

in management

• Longer procedures in

the decision-making

process

• Higher risk of sleeping

partners


www.who.int/gard

Involving new potential partners

according to a plan

• Decision on strategic plan: what the Alliance aims at carrying out

• Analysis of gaps and unmet needs

• Call for new partners in order to fill unmet needs

• Avoid inviting new partners without matching expected outputs and outcome

FIND THE MATCHING PARTNER


www.who.int/gard

Two scenarios

FIRST parties

going to different

directions

without reaching

the goal

SECOND

partners agreeing on a

plan and working

together towards a

common goal

GARD collaborating parties - WHO · Global Alliance against Chronic Respiratory Diseases GARD...

Documents

Transcript of GARD collaborating parties - WHO · Global Alliance against Chronic Respiratory Diseases GARD...